Trey Mullinax Receives Six-Month PGA Tour Ban for Anti-Doping Violation
Overview
Former PGA Tour winner Trey Mullinax has been handed a six-month suspension after testing positive for a substance banned under the World Anti-Doping Agency (WADA) guidelines. The penalty, announced July 30, 2026, makes him eligible to return on January 16, 2027.
What Happened
The PGA Tour confirmed Mullinax violated its Anti-Doping Policy's ban on performance-enhancing substances, though the Tour declined to name the specific substance involved. Mullinax accepted his suspension and cooperated fully with the investigation.
Mullinax's Statement
In a personal statement, Mullinax acknowledged full responsibility while providing some context: he had used a medication to treat a condition originally diagnosed during his college years, without first obtaining approval under the Tour's Anti-Doping Policy. He was careful to stress that gaining a competitive edge was never his intention.
"I have never taken any substance with the intention of gaining a competitive advantage."
He framed his violation as a failure of due diligence rather than intentional cheating, acknowledging that ignorance of the rules does not constitute an excuse.
Career Context
Mullinax won the Barbasol Championship in 2022 and has two Korn Ferry Tour victories to his name. He made 23 starts in 2025, finishing 150th in the FedEx Fall standings for conditional status, and played just two events in 2026 before his suspension was announced.
Strokeslab's Take
This case echoes the 2023 Byeong Hun An incident, where a common over-the-counter remedy triggered a positive test — a reminder that even routine medication requires careful vetting against WADA's prohibited list for Tour professionals.
Mullinax's case is a sobering reminder that WADA compliance extends to everyday medications — for tour professionals, even routine healthcare decisions carry career-defining consequences.